Latest Series C+ Funding Rounds
Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.
- Rounds
- 572 All time
- Disclosed funding
- $283.5B 494 disclosed amounts
- Median round
- $126M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| b bit.bioCompany profile Creates functional, human-relevant cells and models for research, drug discovery, and development Creates functional, human-relevant cells and models for research, drug discovery, and development | $50M | Series CSeries C+ | Biotech | United Kingdom | Investors | |
FineHeartCompany profile Develops cardiology devices, including the fully implantable FlowMaker system. Develops cardiology devices, including the fully implantable FlowMaker system. | €83M | Series CSeries C+ | Healthtech | France | Investors | |
Luxury PresenceCompany profile Luxury Presence provides an AI-based growth platform for real estate agents. Luxury Presence provides an AI-based growth platform for real estate agents. | $37M | Series CSeries C+ | Developer tools | United States | Investors | |
| C CyeraCompany profile Provides a data security and AI governance platform helping enterprises control what AI can see and do Provides a data security and AI governance platform helping enterprises control what AI can see and do | $400M | Series FSeries C+ | Cybersecurity | United States | Investors | |
| V Develops and manufactures insulin patch pump systems for diabetes management | $13M | Series DSeries C+ | Healthtech | Netherlands | Investors | |
| PM Parabilis MedicinesCompany profile Develops medicines targeting historically undruggable protein targets in cancer Develops medicines targeting historically undruggable protein targets in cancer | $305M | Series FSeries C+ | Biotech | United States | Investors Alderline GroupARCH Venture Partners +21Catalio Capital ManagementCormorant Asset ManagementFarallon Capital ManagementFidelity Management & Research CompanyForesite CapitalFrazier Life SciencesGeneral CatalystGVHBM HealthcareInvusJanus Henderson InvestorsMarshall WaceMilky Way InvestmentsNextech InvestRA Capital ManagementRock Springs CapitalSamsara BioCapitalSixty Degree CapitalSoleus CapitalT. Rowe Price AssociatesvenBio Partners | |
| RM Rakuten MedicalCompany profile Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment | $100M | Series FSeries C+ | Biotech | United States | Investors | |
| ST Uses cells as sensors to uncover first-in-class medicines | $200M | Series CSeries C+ | Biotech | United States | Investors | |
| S Provides commerce operating system for brands to sell globally | $100M | Series CSeries C+ | Ecommerce | United Kingdom | Investors | |
| x xAICompany profile xAI develops the Grok family of AI models and applications for consumers, developers and organizations. xAI develops the Grok family of AI models and applications for consumers, developers and organizations. | $20B | Series ESeries C+ | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Andreessen Horowitz (a16z)
Isomorphic Labs, Northwood Space, Kalshi
44rounds5led - 2General Catalyst
Mercor, Clara, Nominal
44rounds1led - 3Sequoia Capital
Isomorphic Labs, LangChain, Nominal
43rounds8led - 4Lightspeed
Payhawk, Nominal, Fractile
39rounds7led - 5NVIDIA
Agile Robots, Mercor, fal
36rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.